Vistagen Therapeutics, Inc. · NASDAQ:VTGN

Commodore Capital LP reported a 9.90% stake in Vistagen Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Commodore Capital LP reported a 9.90% stake in Vistagen Therapeutics, Inc., 4,383,508 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
9.90%
Shares
4,383,508
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Commodore Capital LP9.90%4,383,508
Commodore Capital Master LP9.90%4,383,508
Robert Egen Atkinson9.90%4,383,508
Michael Kramarz9.90%4,383,508

Source

View original at SEC

Related